1. A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India. Issue 1 (31st December 2022) Authors: Reddy, Raghu; Reddy, Bhargav; Sarangi, Vamshi; Reddy, Siddharth; Ella, Raches; Vadrevu, Krishna Mohan Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India. Issue 1 (31st January 2022) Authors: Reddy, Raghu; Reddy, Bhargav; Sarangi, Vamshi; Reddy, Siddharth; Ella, Raches; Vadrevu, Krishna Mohan Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India. Issue 7 (3rd July 2018) Authors: Ella, Raches; Bobba, Radhika; Muralidhar, Sanjay; Babji, Sudhir; Vadrevu, Krishna Mohan; Bhan, Maharaj Kishan Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 7(2018) Page Start: 1791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants. Issue 31 (18th July 2019) Authors: Ella, Raches; Babji, Sudhir; Ciarlet, Max; Blackwelder, William C.; Vadrevu, Krishna Mohan Journal: Vaccine Issue: Volume 37:Issue 31(2019) Page Start: 4407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Issue 10317 (11th December 2021) Authors: Ella, Raches; Reddy, Siddarth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay K; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; M... Journal: Lancet Issue: Volume 398:Issue 10317(2021) Page Start: 2173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. Issue 9 (September 2022) Authors: Vadrevu, Krishna Mohan; Reddy, Siddharth; Jogdand, Harsh; Ganneru, Brunda; Mirza, Nizam; Tripathy, Virendra Nath; Singh, Chandramani; Khalatkar, Vasant; Prasanth, Siddaiah; Rai, Sanjay; Ella, Raches; Blackwelder, William; Prasad, Sai; Ella, Krishna Journal: Lancet infectious diseases Issue: Volume 22:Issue 9(2022) Page Start: 1303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees. (7th May 2021) Authors: Yadav, Pragya D; Sapkal, Gajanan N; Abraham, Priya; Ella, Raches; Deshpande, Gururaj; Patil, Deepak Y; Nyayanit, Dimpal A; Gupta, Nivedita; Sahay, Rima R; Shete, Anita M; Panda, Samiran; Bhargava, Balram; Mohan, V Krishna Journal: Clinical infectious diseases Issue: Volume 74:Number 2(2022) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine. (20th December 2019) Authors: Vadrevu, Krishna Mohan; Potula, Venugopal; Khalatkar, Vasant; Mahantshetty, Niranjana S; Shah, Atish; Ella, Raches Journal: Journal of infectious diseases Issue: Volume 222:Number 9(2020) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination. Issue 45 (29th October 2021) Authors: Vadrevu, Krishna Mohan; Raju, Dugyala; Rani, Sandhya; Reddy, Siddharth; Sarangi, Vamshi; Ella, Raches; Javvaji, Bhuvaneswara; Mahantshetty, Niranjana S.; Battu, Sudhakar; Levine, Myron M. Journal: Vaccine Issue: Volume 39:Issue 45(2021) Page Start: 6682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Issue 5 (May 2021) Authors: Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya; Abraham, Priya; Panda, Samiran; Gupta, Nivedita; Reddy, Prabhakar; Verma, Savita; Kumar Rai, Sanjay; Singh, Chandramani; Redkar, Sagar Vivek; Gill... Journal: Lancet infectious diseases Issue: Volume 21:Issue 5(2021) Page Start: 637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗